GenBio AI (@genbioai) header
GenBio AI (@genbioai) profile picture

Building the world’s first AI-Driven Digital Organism (AIDO). We're hiring: https://nitter.cf/t.co/JwdGBJvhkL

Palo Alto | Paris | Abu Dhabi
Joined September 2024
Photo by GenBio AI (@genbioai)Photo by GenBio AI (@genbioai)Photo by GenBio AI (@genbioai)Photo by GenBio AI (@genbioai)Photo by GenBio AI (@genbioai)Photo by GenBio AI (@genbioai)Photo by GenBio AI (@genbioai)Photo by GenBio AI (@genbioai)Photo by GenBio AI (@genbioai)Photo by GenBio AI (@genbioai)
Today we're releasing a preview of AIDO Cell, a world model of the human cell. It simulates one cell across DNA, RNA, protein, through regulatory networks and whole-cell behavior. Not four models handing results to each other. One system.
64
332
115
2,114
656,052
Our Co-Founder and CTO @dasongle is speaking at the AI for Drug Discovery Bridging the Translation Gap workshop at #NeurIPS2026 in Sydney. Catch his session on Dec 11 on world models for biology and building stateful virtual cell simulators.
6
279
GenBio AI retweeted
Replying to @nytimes
@nytimes covered @genbioai and its #VirtualCell work today, following a great conversation with the brilliant @carlzimmer! While companies like Isomorphic claim to "cure all diseases" with a drug design engine, we focus on "simulating diseases" for Virtual Trial of Drugs or Other Therapeutics, as well as for biological research, via virtual cell, virtual tissue, and eventually AI-driven digital organism (#AIDO). It is perhaps less ambitious, but in my opinion more realistic and accessible. We have a great team that includes luminaries like David Baker, @Prof_Lundberg, @zivbj, @deboramarks, @segal_eran, @dasongle, and many more superb engineers and researchers. Come join us! nytimes.com/2026/11/18/scien…
1
2
7
609
Replying to @nytimes
@nytimes examined the race to build AI virtual cells and the debate around whether computers can match the complexity of life. Carl Zimmer highlights our co-founders @ericxing and David Baker on why we are building a world model to simulate how cells change over time. Read the full piece: nyti.ms/4zVHrle
2
5
8
710
GenBio AI retweeted
AIDO Cell simulated every layer of this HepG2 cell, from gene expression to cell shape, in one model. Outputs are delivered through the API and explorable in AIDO Lab. Want to run your own experiments? Join the waitlist: genbio.ai/waitlist/
3
13
1,330
AIDO Cell simulated every layer of this HepG2 cell, from gene expression to cell shape, in one model. Outputs are delivered through the API and explorable in AIDO Lab. Want to run your own experiments? Join the waitlist: genbio.ai/waitlist/
3
13
1,330
Our CTO @dasongle joined the @adia_lab Symposium to showcase AIDO Cell, tracking continuous biological state across multiscale experiments. Thanks @adia_lab for having us. AIDO Cell waitlist: genbio.ai/waitlist/
4
604
The ADIA Lab Symposium opens in Abu Dhabi on Monday, October 26. @dasongle will be delivering a keynote on day two. @adia_lab is an independent research institute working in data and computational sciences, and this is its flagship event. Le's talk is AIDO Cell: A General-Purpose Simulator for Cell Biology.
1
3
4
713
GenBio AI retweeted
Drugs that fail in clinical trials most often fail on efficacy or unexpected toxicity. In @Forbes, our CTO @dasongle traces both to one gap: no tool can yet predict how a molecule behaves inside a living cell. That gap is what AIDO Cell is for. bit.ly/3VjUoGn
3
2
589
Drugs that fail in clinical trials most often fail on efficacy or unexpected toxicity. In @Forbes, our CTO @dasongle traces both to one gap: no tool can yet predict how a molecule behaves inside a living cell. That gap is what AIDO Cell is for. bit.ly/3VjUoGn
3
2
589
Replying to @dasongle
@dasongle is a featured panelist on the opening panel at Molecules, Models & Agents in San Francisco on Monday, October 5. From Data to Discovery: AI Across Digital Health and Digital Biology, moderated by @dr_alphalyrae of @NVIDIA NVentures, with Michael Aratow of @EllipsisHealth and @kavi_deniz of @tamarindbio. #SFTechWeek
1
464
GenBio AI retweeted
We discussed fundamental issues in the definition, model architecture, computational algorithm, and meaningful evaluation/qualification of a fully steerable virtual cell that is multi-modal, multi-scale, dynamic, and stateful. @dasongle , @genbioai , @mbzuai , @CarnegieMellon cell.com/cell/fulltext/S0092…
3
10
67
3,682
Out today in @cellpressnews: "A world model of the virtual cell," from our co-founders @ericxing and @dasongle. Their definition of a virtual cell is a stateful, multi-modal, multi-scale simulator, judged on whether it stays coherent across a sequence of interventions. Open access: cell.com/cell/fulltext/S0092…
1
8
1
35
3,064
A model that makes one prediction and resets only captures a snapshot. AIDO Cell holds the cell's state: perturb it, read it out, then further experiment on the cell you just changed. @DrugDiscovNews on where the virtual cell came from, what's left to prove and how world models are redefining cellular simulation: drugdiscoverynews.com/what-i…
1
2
15
989
More coverage from @fwpharma, @TLDRnewsletter, @BigDATAwireNews, The Innermost Loop (by @alexwg), and other prominent newsletters across AI and biotech.
1
1,623
@LongevityTech asks: “Can AI put the cell back together?” They look at how AIDO Cell links DNA, RNA, protein and whole-cell behavior, and how it ‘remembers’ what has already happened to the cell previously: longevity.technology/news/ca…
1
1
1
2,080
@statnews: AIDO Cell is built to predict how a cell’s overall machinery responds to a drug or a gene knockout. The publication compares it to AlphaFold but for a different domain and with added complexity: statnews.com/2026/08/18/davi…
1
1
1
2,930
It’s been a week since we revealed AIDO Cell. Here’s some of the coverage that encapsulates the overall mission and reception (🧵):
4
3
1
10
45,639